Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Gross Profit (2018 - 2025)

Exagen (XGN) has disclosed Gross Profit for 8 consecutive years, with $9.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 8.6% year-over-year to $9.2 million, compared with a TTM value of $38.8 million through Dec 2025, up 17.18%, and an annual FY2025 reading of $38.8 million, up 17.18% over the prior year.
  • Gross Profit was $9.2 million for Q4 2025 at Exagen, down from $10.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $10.4 million in Q2 2025 and bottomed at $1.5 million in Q2 2022.
  • Average Gross Profit over 5 years is $7.5 million, with a median of $7.9 million recorded in 2021.
  • The sharpest move saw Gross Profit crashed 79.13% in 2022, then surged 443.26% in 2023.
  • Year by year, Gross Profit stood at $7.8 million in 2021, then fell by 15.77% to $6.5 million in 2022, then increased by 24.77% to $8.1 million in 2023, then rose by 4.08% to $8.5 million in 2024, then rose by 8.6% to $9.2 million in 2025.
  • Business Quant data shows Gross Profit for XGN at $9.2 million in Q4 2025, $10.1 million in Q3 2025, and $10.4 million in Q2 2025.